![Susan Benton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Benton
Direktor/Vorstandsmitglied bei
TARSIER PHARMA LTD.
Vermögen: 904 847 $ am 31.07.2026
Profil
Ms. Susan K.
Benton is an Independent Director at Opus Genetics, Inc., a General Manager & Head-United States at Thea Pharma, Inc., an Independent Non-Executive Director at Tarsier Pharma Ltd., a Chief Commercial Officer at Sirion Holdings, Inc. and an Owner at i2Eye Consulting LLC.
She is on the Board of Directors at Omma Therapeutics, Inc., OcuSub, Inc., Opus Genetics, Inc., Translatum Medicus, Inc. and Tarsier Pharma Ltd. Ms. Benton was previously employed as a President & Chief Executive Officer by Thea Pharma, Inc. /US/, a Head-Global Product Strategy & New Ophthalmic by Shire, Inc., a VP-Professional Sales & Head-Diversified Products by Bausch & Lomb, Inc., a Chief Commercial Officer, SVP-Sales & Marketing by Sirion Therapeutics, Inc., a Vice President-Consumer & Professional Sales by Lifescan, Inc., a VP-Professional Sales & Head-Diversified Products by Bausch & Lomb, Inc., a Senior Manager by Aventis Pasteur, Inc., and a Head-Media Relations by Thoratec Corp.
She also served on the board at Ripple Therapeutics Corp.
She received her undergraduate degree from Muhlenberg College and an MBA from the University of South Florida.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 243’894 ( 0.3% ) | 904 847 $ | 31.07.2026 |
Aktive Positionen von Susan Benton
| Unternehmen | Position | Beginn |
|---|---|---|
| OPUS GENETICS, INC. | Direktor/Vorstandsmitglied | 01.11.2020 |
| TARSIER PHARMA LTD. | Direktor/Vorstandsmitglied | 01.03.2019 |
Sirion Holdings, Inc.
 Sirion Holdings, Inc. BiotechnologyHealth Technology Provides pharmaceutical products and medical devices for the ophthalmic market | Gründer | 25.08.2009 |
Translatum Medicus, Inc.
 Translatum Medicus, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides preclinical drug development services | Direktor/Vorstandsmitglied | 01.07.2019 |
i2Eye Consulting LLC
 i2Eye Consulting LLC Specialty StoresRetail Trade Provides opthalmic consulting services | Corporate Officer/Principal | - |
Thea Pharma, Inc.
 Thea Pharma, Inc. Part of Thea Holding SAS, Thea Pharma, Inc. is a Canadian subsidiary of Laboratoires Théa, a European pharmaceutical company specializing in ophthalmic care since 1994. The company is based in Toronto, Canada. Thea Pharma focuses on advancing eye health through innovation, particularly with preservative-free eye care products designed to protect the ocular surface and reduce irritation and side effects associated with preservatives. Its product portfolio addresses conditions such as dry eye, glaucoma, and lid hygiene, and features proprietary technologies like the ABAK® multi-dose bottle and S.F.T. Steri-Free Technology®. The company supports education and partnership with eye care professionals through initiatives such as the Théa Academy. Its offerings include a range of eye-care products regulated or approved by the U.S. Food and Drug Administration, including Zioptan®, AcellFX™, Cosopt®, Cosopt® PF, Azasite®, Akten®, Betimol®, Ivizia™ dry-eye drops and eyelid hygiene products, and Iyuzeh™. | Corporate Officer/Principal | 01.08.2019 |
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology Develops biological products | Direktor/Vorstandsmitglied | 05.11.2020 |
Ehemalige bekannte Positionen von Susan Benton
| Unternehmen | Position | Ende |
|---|---|---|
Thea Pharma, Inc. /US/
 Thea Pharma, Inc. /US/ Pharmaceuticals: MajorHealth Technology Manufactures and sells eye care pharmaceuticals | Vorstandsvorsitzender | 01.07.2024 |
Ripple Therapeutics Corp.
 Ripple Therapeutics Corp. BiotechnologyHealth Technology Develops and discovers ophthalmic therapeutics | Direktor/Vorstandsmitglied | 01.07.2024 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Susan Benton
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Health Technology |
Thoratec Corp.
 Thoratec Corp. Medical SpecialtiesHealth Technology Manufactures and distributes circulatory support devices for heart failure patients | Health Technology |
Sanofi Pasteur, Inc.
 Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Provides vaccines for the prevention and treatment of disease | Health Technology |
Sirion Holdings, Inc.
Sirion Holdings, Inc. BiotechnologyHealth Technology Provides pharmaceutical products and medical devices for the ophthalmic market | Health Technology |
Muhlenberg College
 Muhlenberg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lifescan, Inc.
 Lifescan, Inc. Medical/Nursing ServicesHealth Services Manufactures health care products | Health Services |
Sirion Therapeutics, Inc.
 Sirion Therapeutics, Inc. BiotechnologyHealth Technology Provides biopharmaceutical products and services | Health Technology |
i2Eye Consulting LLC
i2Eye Consulting LLC Specialty StoresRetail Trade Provides opthalmic consulting services | Retail Trade |
Shire, Inc.
 Shire, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology Develops biological products | Health Technology |
Tarsier Pharma Ltd.
 Tarsier Pharma Ltd. BiotechnologyHealth Technology Operates as a clinical-stage company that develops and commercializes novel therapeutic treatments for autoimmune eye disease & inflammatory ocular diseases | Health Technology |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
Translatum Medicus, Inc.
Translatum Medicus, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides preclinical drug development services | Health Technology |
Ripple Therapeutics Corp.
Ripple Therapeutics Corp. BiotechnologyHealth Technology Develops and discovers ophthalmic therapeutics | Health Technology |
Thea Pharma, Inc.
Thea Pharma, Inc. Part of Thea Holding SAS, Thea Pharma, Inc. is a Canadian subsidiary of Laboratoires Théa, a European pharmaceutical company specializing in ophthalmic care since 1994. The company is based in Toronto, Canada. Thea Pharma focuses on advancing eye health through innovation, particularly with preservative-free eye care products designed to protect the ocular surface and reduce irritation and side effects associated with preservatives. Its product portfolio addresses conditions such as dry eye, glaucoma, and lid hygiene, and features proprietary technologies like the ABAK® multi-dose bottle and S.F.T. Steri-Free Technology®. The company supports education and partnership with eye care professionals through initiatives such as the Théa Academy. Its offerings include a range of eye-care products regulated or approved by the U.S. Food and Drug Administration, including Zioptan®, AcellFX™, Cosopt®, Cosopt® PF, Azasite®, Akten®, Betimol®, Ivizia™ dry-eye drops and eyelid hygiene products, and Iyuzeh™. | |
Thea Pharma, Inc. /US/
Thea Pharma, Inc. /US/ Pharmaceuticals: MajorHealth Technology Manufactures and sells eye care pharmaceuticals | Health Technology |
